Fc receptor signaling and trafficking: A connection for antigen processing

Immunological Reviews

Volumn 172, Issue , 1999, Pages 279-284

  Amigorena, Sebastian ^a   Bonnerot, Christian ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; EFFECTOR CELL; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033430995     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01372.x     Document Type: Review

References (35)

1. 1. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457-492.
2. 2. Mostov K. Protein traffic in polarized epithelial cells: the polymeric immunoglobulin receptor as a model system. J Cell Sci 1993;17(Suppl):21-26.
3. 3. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989;337:184-187.
4. 4. Daeron M. Fc receptor biology. Annu Rev Immunol 1997;15:203-234.
5. 5. Reth M. Antigen receptor tail clue. Nature 1989;338:383.
6. 6. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 1995;155:3281-3285.
7. 7. Ravetch JV, Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998;16:421-432.
8. 8. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999;189:179-185.
9. 9. Amigorena S, et al. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 1992;256:1808-1812.
10. 10. Cambier JC. Inhibitory receptors abound? Proc Natl Acad Sci USA 1997;94:5993-5995.
11. 11. Ravetch JV. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 1986;234:718-725.
12. 12. Choquet D, Partiseti M, Amigorena S, Bonnerot C, Fridman WH, Korn H. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol 1993;121:355-363.
13. 13. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1993;76:263-274.
14. 14. Daeron M, Latour S, Huckel C, Bonnerot C, Fridman WH. Murine Fc γ RII and III in mast cell activation. Immunobiology 1992;185:159-174.
15. 15. Latour S, Bonnerot C, Fridman WH, Daeron M. Induction of tumor necrosis factor-α production by mast cells via Fc γ R. Role of the Fc γ RIII γ subunit. J Immunol 1992;149:2155-2162.
16. 16. Bonnerot C, Amigorena S, Choquet D, Pavlovich R, Choukroun V, Fridman WH. Role of associated γ-chain in tyrosine kinase activation via murine Fc γ RIII. EMBO J 1992;11:2747-2757.
17. 17. Amigorena S, Bonnerot C. Role of B-cell and Fc receptors in the selection of T-cell epitopes. Curr Opin Immunol 1998;10:88-92.
18. 18. Amigorena S, Salamero J, Davoust J, Fridman WH, Bonnerot C. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature 1992;358:337-341.
19. 19. Bonnerot C, et al. Syk protein tyrosine kinase regulates Fc receptor γ -chain-mediated transport to lysosomes. EMBO J 1998;17:4606-4616.
20. 20. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996;5:591-604.
21. 21. Liscovitch M, Cantley LC. Signal transduction and membrane traffic: the PITP/phosphoinositide connection. Cell 1995;81:659-662.
22. 22. Buhl AM, Cambier JC. Co-receptor and accessory regulation of B-cell antigen receptor signal transduction. Immunol Rev 1997;160:127-138.
23. 23. Joly M, Kazlauskas A, Corvera S. Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking. J Biol Chem 1995;270:13225-13230.
24. 24. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-850.
25. 25. Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol Rev 1987;99:39-51.
26. 26. Fridman WH, Bonnerot C, Daeron M, Amigorena S, Teillaud JL, Sautes C. Structural bases of Fcγ receptor functions. Immunol Rev 1992;125:49-76.
27. 27. Sallusto F, Cella M, Danieli C, Linzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
28. 28. Regnault A, et al. Fcγ R-mediated induction of dendritic cell maturation and MHC class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999;189:371-380.
29. 29. Manca F, Fenoglio D, Li PG, Kunkl A, Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991;173:37-48.
30. 30. Amigorena S, Lankar D, Eriken V, Gapin L, Viguier M, Bonnerot C. Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J Exp Med 1998;187:505-515.
31. 31. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994;369:113-120.
32. 32. Pierre P. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-792.
33. 33. Fanger NA, et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fcγ RI (CD64) expressed on human blood dendritic cells. J Immunol 1997;158:3090-3098.
34. 34. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995;3:783-791.
35. 35. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997;27:280-288.